Old Web
English
Sign In
Acemap
>
authorDetail
>
Nancy Gallagher
Nancy Gallagher
Merck & Co.
Medicine
Immunogenicity
Internal medicine
Population
Interim analysis
2
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial.
2021
Human Vaccines & Immunotherapeutics
Vu Dinh Thiem
Nguyen Dang Quang
Nguyen Hai Tuan
Kyeongmi Cheon
Nancy Gallagher
Alain Luxembourg
Cyrus Badshah
Show All
Source
Cite
Save
Citations (0)
Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
2020
Papillomavirus Research
Sven-Eric Olsson
Jaime Alberto Restrepo
Julio C. Reina
Punnee Pitisuttithum
Àngels Ulied
Meera Varman
Pierre Van Damme
Edson D. Moreira
Daron Gale Ferris
Stanley L. Block
Oliver M. Bautista
Nancy Gallagher
Jennifer McCauley
Alain Luxembourg
Show All
Source
Cite
Save
Citations (9)
1